Molecular and neuroanatomical properties of the endogenous opioid system: Implications for treatment of opiate addiction

Seminars in the Neurosciences

Volumn 9, Issue 3-4, 1997, Pages 70-83

  Akil, Huda ^a   Meng, Fan ^a   Devine, Darragh P ^a   Watson, S J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anatomy; Molecular biology; Opioid peptides; Opioid receptors; receptors

Indexed keywords

DELTA OPIATE RECEPTOR; DOPAMINE RECEPTOR; ENDORPHIN; KAPPA OPIATE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL TISSUE; BEHAVIOR; BINDING KINETICS; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; ENDOCYTOSIS; HUMAN; INTERNALIZATION; MOLECULAR BIOLOGY; MOLECULAR CLONING; MORPHINE TOLERANCE; NEUROANATOMY; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0030704274     PISSN: 10445765     EISSN: None     Source Type: Journal    
DOI: 10.1006/smns.1997.0108     Document Type: Article

References (110)

1. 1. Akil, H., Mayer, D. J., and Liebeskind, J. C. (1976) Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 191, 961-962.
2. 2. Akil, H., Mayer, D. J., Liebeskind, J. C., and Fessard, M. A. (1972) Comparison chez le rat entre l'analgesie induite par stimulation de la substance grise peri-aqueducale et l'analgesie morphinique. C R Acad Sci Paris Ser D 274, 3603-3605.
3. 3. Akil, H., and Watson, S. J. (1994) Cloning of kappa opioid receptors: Functional significance and future directions. In Neuroscience: From the Molecular to the Cognitive (F. E. Bloom, Ed.). Elsevier Publishers, Amsterdam.
4. 4. Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., and Walker, J. M. (1984) Endogenous opioids: Biology and function. In Annual Review of Neuroscience (W. M. Cowan, Ed.), pp. 223-255. Annual Reviews, Inc., Palo Alto.
5. 5. Akil, H., Young, E., Watson, S. J., and Coy, D. (1981) Opiate binding properties of naturally occurring N-and C-terminus modified beta-endorphin. Peptides 2, 289-292.
6. 6. Avidor-Reiss, T., Nevo, I., Levy, R., Pfeuffer, T., and Vogel, Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma. J. Biol. Chem. 271, 21309-21315.
7. 7. Bals-Kubik, R., Herz, A., and Shippenberg, T. S. (1988) β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Arch. Pharmacol. 338, 392-396.
8. 8. Beckett, A. H., and Caesy, A. F. (1954) Synthetic analgesics: Stereochemical considerations. J. Pharm. Pharmacol. 6, 986-1001.
9. 9. Befort, K., Mattei, M.-G., Roeckel, N., and Kieffer, B. (1994) Chromosomal localization of the δ opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization. Genomics 20, 143-145.
10. 10. Bloom, F. E., Rossier, J., Battenberg, E., Bayon, A., French, E., Henricksen, S. J., Siggins, G. R., Segal, D., Browne, R., Ling, N., and Guillemin, R. (1978) Beta-endorphin: Cellular localization, electrophysiological and behavioral effects. In Advances in Biochemistry and Psychopharmacology: The Endorphins. (E. Costa, M. Trabucchi, Eds.) Vol. 18, pp. 89-109. Raven Press, New York.
11. 11. Bunzow, J. R., Saez, C., Mortrud, M., Bouvier, C., Wiulliams, J. T., Low, M., and Grandy, D. K. (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. FEBS Lett. 347, 279-283.
12. 12. Burt, A. R., Carr, I. C., Mullaney, I., Anderson, N. G., and Milligan, G. (1996) Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: Effects of receptor expression levels and comparisons with G-protein activation. Biochem. J. 320, 227-235.
13. 13. Chang, K.-J., and Cuatrecasas, P. (1979) Multiple opiate receptors: Enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 254, 2610-2618.
14. 14. Chen, Y., Mestek, A., Liu, J., Hurley, J. A., and Yu, L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
15. 15. Chesselet, M., Cheramy, A., Reisine, T., Lubetzki, C., Desban, M., and Glowinski, J. (1983) Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantive nigrae of the cat. Brain Res. 258, 229-242.
16. 16. Childers, S. R. (1993) Opioid receptor-coupled second messenger systems. In Opioids I (A. Herz, Ed.), pp. 189-216. Springer-Verlag, Berlin.
17. 17. Cooper, S. J. (1991) Interactions between endogenous opioids and dopamine: Implications for reward and aversion. In The Mesolimbic Dopamine System: From Motivation to Action (P. Willner and J. Scheel-Kruger, Eds.), pp. 331-366. Wiley, England.
18. 18. Curran, E. J., and Watson, S. J. (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: A double in situ hybridization study. J. Comp. Neurol. 361, 57-76.
19. 19. Devine, D. P., Leone, P., Pocock, D., and Wise, R. A. (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266, 1236-1246.
20. 20. Devine, D. P., Reinscheid, R., Monsma, F., Civelli, O., and Akil, H. (1996) The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727, 225-229.
21. 21. Devine, D. P., Taylor, L. P., Reinscheid, R. K., Monsma, F. J., Civelli, O., and Akil, H. (1996) Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21, 1387-1396.
22. 22. Devine, D. P., and Wise, R. A. (1994) Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14, 1978-1984.
23. 23. Di Chiara, G., and Imperato, A. (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067-1080.
24. 24. Evans, C. J., Keith, D. E., Jr., Morrison, H., Magendzo, K., and Edwards, R. H. (1992) Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
25. 25. Fukuda, K., Kato, S., Mori, K., Nishi, M., and Takeshima, H. (1993) Primary structures and expression from cDNAs of rat opioid receptor δ-and μ-subtypes. FEBS Lett. 327, 311-314.
26. 26. Fukuda, K., Kato, S., Morikawa, H., Shoda, T., and Mori, K. (1996) Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67, 1309-1316.
27. 27. Fukuda, K., Terasako, K., Kato, S., and Mori, K. (1995) Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ-and μ-opioid receptors. FEBS Lett. 373, 177-181.
28. 28. Gaudriault, Nouel, D., Dal Farra, C., Beaudet, A., and Vincent, J.-P. (1997) Receptor-induced internalization of selective peptidic μ and opioid ligands. J. Biol. Chem. 272, 2880-2888.
29. 1 receptor for substance P and non-peptide agonist. Nature 362, 345-348.
30. 30. Goldstein, A., Lowney, L. I., and Pal, B. K. (1971) Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA 68, 1742-1747.
31. 31. Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., and Hood, L. (1979) Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA 76, 6666-6670.
32. 32. Graybiel, A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. TINS 13, 244-254.
33. 33. Grevel, J., and Sadee, W. (1983) An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans. Science 221, 1198-1200.
34. 34. Gulya, K., Pelton, J., Hruby, V., and Yamamura, H. (1986) Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sci. 30, 2221-2229.
35. 35. Gutstein, H. B., Rubic, E. A., Mansour, A., Akil, H., and Woodgett, J. R. (1997) Opioid effects on protein kinase signaling cascades. Anesthesiology, in press.
36. 36. Handa, B., Lane, A., Lord, J., Morgan, B., Ranee, M., and Smith, C. (1981) Analogues of beta-LPH 61-64 possessing selective agonist activity at mu opiate receptors. Eur. J. Pharmacol. 70, 531-540.
37. 37. Heimer, L., Switzer, R. D., and Van Hoesen, G. W. (1982) Ventral striatum and ventral pallidum. Components of the motor system? TINS 5, 83-87.
38. 38. Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., and Wohltmann, C. (1991) Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41, 89-125.
39. 39. Hokfelt, T., Ljungdahl, A., Terenius, L., Elde, R., and Nilsson, C. (1977) The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci. Lett. 5, 25-31.
40. 40. Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., and Morris, H. R. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577-579.
41. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257, 1069-1075.
42. 42. Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., and von Zastrow, M. (1996) Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
43. 43. Kieffer, B., Befort, K., Gaveriaux-Ruff, C., and Hirth, C. (1992) The delta opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
44. 44. Kosterlitz, H. W., and Waterfield, A. A. (1975) In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol. 15, 29-47.
45. 45. Li, C. H., and Chung, D. (1976) Isolation and structure of a triakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. USA 73, 1145-1148.
46. 46. Li, L. Y., and Chang, K. J. (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol. 50, 599-602.
47. 47. Lord, J., Waterfield, A., Hughes, J., and Kosterlitz, H. (1977) Endogenous opioid peptides: Multiple agonists and receptors. Nature (London) 267, 495-499.
48. 48. Mains, R. E., Eipper, B. A., and Ling, N. (1977) Common precursor to corticotropins and endorphins. Proc. Natl. Acad. Sci. USA 74, 3014.
49. 49. Mansour, A., Fox, C. A., Burke, A., Meng, F., Thompson, R. C., Akil, H., and Watson, S. J. (1994) Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. J. Comp. Neurol. 350, 412-438.
50. 1 receptor mRNA distribution in the rat CNS: Comparison to kappa receptor binding and prodynorphin mRNA. Cell. Mol. Neurosci. 5, 124-144.
51. 51. Mansour, A., Fox, C. A., Thompson, R. C., Akil, H., and Watson, S. J. (1994b) Mu-opioid receptor mRNA expression in the rat CNS: Comparison to mu-receptor binding. Brain Res. 643, 245-265.
52. 52. Mansour, A., Hoversten, M. T., Taylor, L. P., Watson, S. J., and Akil, H. (1995) The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores. Brain Res. 700, 89-98.
53. 53. Mansour, A., Khatchaturian, H., Lewis, M. E., Akil, H., and Watson, S. J. (1988) Anatomy of CNS opioid receptors. TINS 11, 308-314.
54. 54. Mansour, A., Meng, F., Meador-Woodruff, J., Taylor, L., Civelli, O., and Akil, H. (1992) Site-directed mutagenesis of the human D2 receptor. Eur. J. Pharmacol. 227, 205-214.
55. 55. Mansour, A., Taylor, L. P., Fine, J. L., Thompson, R. C., Hoversten, M. T., Mosberg, H. I., Watson, S. J., and Akil, H. (1997) Key residues defining the m opioid receptor binding pocket: A site-directed mutagenesis study. J. Neurochem. 68, 344-353.
56. 56. Martin, W., Eades, C., Thompson, J., Huppler, R., and Gilbert, P. (1976) The effects of morphine and nalorphine-like drugs in nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
57. 57. Meng, F., Hoversten, M., Thompson, R. C., Taylor, L., Watson, S. J., and Akil, H. (1995) A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors: Potential role of extracellular domains. J. Biol. Chem. 270, 12730-12736.
58. 58. Meng, F., Ueda, Y., Thompson, R. C., Hoversten, M. T., Taylor, L. P., Watson, S. J., and Akil, H. (1996) Mapping the receptor domains critical for the binding selectivity of δ opioid receptor ligands. Eur. J. Pharmacol. 311, 285-292.
59. 59. Meng, F., Xie, G. X., Thompson, R. C., Mansour, A., Goldstein, A., Watson, S. J., and Akil, H. (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. USA 90, 9954-9958.
60. 60. Mestek, A., Hurley, J. H., Bye, L. S., Campbell, A. D., Chen, Y., Tian, M., Liu, J., Schulman, H., and Yu, L. (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15, 2396-2406.
61. 1 receptor. Nature 377, 532-535.
62. 62. Minami, M., Toya, T., Katao, Y, Maekawa, K., Nakamura, S., Onogi, T., Kaneko, S., and Satoh, M. (1993) Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329, 291-295.
63. 63. Misawa, H., Ueda, H., and Satoh, M. (1990) Kappa-opioid agonist inhibits phospholipasa C, possibly via an inhibition of G-protein activity. Neurosci. Lett. 112, 324-327.
64. 64. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.-L., Moisand, C., Chalon, P., Caput, D., Vassart, G., and Meunier, J.-C. (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33-38.
65. 65. Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J., and Burks, T. F. (1983) Bis-pencillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. USA 80, 5871-5874.
66. 66. Mulder, A., Burger, D., Wardeh, G., Hogenboom, F., and Frankhuyzen, A. (1991) Pharmacological profile of various kappa-agonists at kappa-, mu-and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br. J. Pharmacol. 102, 518-522.
67. 67. Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., Chang, A. C. Y., Cohen, S. N., and Numa, S. (1979) Nucleotide sequence of clones cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278, 423.
68. 68. Narita, M., Narita, M., Mizoguchi, H., and Tseng, L. F. (1995) Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280, R1-3.
69. 69. Negri, L., Potenza, R. L., Corsi, R., and Melchiorri, R (1991) Evidence for two subtypes of δ opioid receptors in rat brain. Eur. J. Pharmacol. 196, 335-336.
70. 70. Oka, T. (1980) Enkephalin receptor in the rabbit ileum. Life Sci. 38, 1889-1898.
71. 71. Pei, G., Kieffer, B. L., Lefkowitz, R. J., and Freedman, N. J. (1995) Agonist-dependent phosphorylation of the mouse delta-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
72. 72. Periyasamy, S., and Hoss, W. (1990) Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sci. 47, 219-225.
73. 73. Pert, C., and Snyder, S. (1973) Opiate receptor; demonstration in nervous tissue. Science 179, 1011-1014.
74. 74. Piros, E. T., Hales, T. G., and Evans, C. J. (1996) Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res. 21, 1271-1488.
75. 75. Portoghese, P., Lipowski, A., and Takemori, A. (1987) Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40, 1287-1292.
76. 76. Portoghese, P., Sultana, M., and Takemori, A. (1988) Natrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
77. 77. Prather, P. L., McGinn, T. M., Claude, P. A., Liu-Chen, L. Y., Loh, H. H., and Law, P. Y. (1995) Properties of a kappa-opioid receptor expressed in CHO cells: Interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. Mol. Brain Res. 29, 336-346.
78. 78. Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., Jr., and Civelli, O. (1995) Orphanin FQ: A neuropeptide that activates an opioid-like G-protein-coupled receptor. Science 270, 792-794.
79. 79. Rothman, R. B., Long, J. B., Bykov, V., Jacobson, A. E., Rice, K. C., and Holaday, J. W. (1988) β-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J. Pharmacol. Exp. Ther. 247, 405.
80. 80. Schulz, R., Fease, E., Wuster, M., and Herz, A. (1979) Selective receptors for β-endorphin on the rat vas deferens. Life Sci. 24, 843-850.
81. 81. Schwyzer, R. (1986) Molecular mechanism of opioid receptor selection. Biochemistry 25, 6335-6342.
82. 82. Shippenberg, T. S., Bals-Kubik, R., and Herz, A. (1987) Motivational properties of opioids: Evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436, 234-239.
83. 83. Shippenberg, T. S., Bals-Kubik, R., Huber, A., and Herz, A. (1991) Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology 103, 209-214.
84. 84. Shippenberg, T. S., Herz, A., Spanagel, R., Bals-Kubik, R., and Stein, C. (1992) Conditioning of opioid reinforcement: Neuroanatomical and neurochemical substrates. Ann. N.Y. Acad. Sci. 654, 347-356.
85. 85. Simon, E., Hiller, J., and Edelman, I. (1973) Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70, 1947-1949.
86. 86. Sofuoglu, M., Portoghese, P. S., and Takemori, A. E. (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257, 676-680.
87. 87. Strader, C. D., Signal, I. S., Candelore, M. R., Rands, E., Hill, W. S., and Dixon, R. A. F. (1988) Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263, 10267-10271.
88. 88. Surratt, C. K., Johnson, P. S., Moriwaki, A., Seidleck, B. K., Blaschak, C. J., Wang, J. B., and Uhl, G. R. (1994) Mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269, 20548-20553.
89. 89. Terenius, L. (1973) Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat brain cortex. Acta Pharmacol. Toxicol. (Copenh) 32, 317-320.
90. 90. Thompson, R. C., Mansour, A., Akil, H., and Watson, S. J. (1993) Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11, 903-913.
91. 91. Trapaidze, N., Keith, D. E., Cvejic, S., Evans, C. J., and Devi, L. A. (1996) Sequestration of the opioid receptor: Role of the c terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285.
92. 92. Trujillo, K. A., and Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
93. 93. Tseng, L. F., and Li, C. H. (1986) Beta-endorphin (1-27) inhibits the spinal beta-endorphin-induced release of met-enkephalin. Int. J. Pept. Protein Res. 27, 394-397.
94. 94. Ueda, H., Miyamae, T., Hayashi, C., Watanabe, S., Fukushima, N., Sasaki, Y., Iwamura, T., and Misu, Y. (1995) Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gil-phospholipase C activation in Xenopus oocytes. J. Neurosci. 15, 7485-7499.
95. 95. Von Voightlander, P., Lahti, R., and Ludens, J. (1983) U-50, 488H: A selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 24, 111-115.
96. 96. Wang, J.-B., Johnson, P. S., Persico, A. M., Hawkins, A. L., Griffin, C. A., and Uhl, G. R. (1994a) Human μ opiate receptor cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338, 217-222.
97. 97. Wang, J. B., Imai, Y, Eppler, C. M., Gregor, P., Spivak, C. E., and Uhl, G. R. (1993) μ Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90, 10230-10234.
98. 98. Wang, J. B., Johnson, P. S., Wu, J. M., Wang, W. F., and Uhl, G. R. (1994b) Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for mu/kappa chimeras. J. Biol. Chem. 269, 25966-25969.
99. 99. Wang, W. W., Shahrestanifar, M., Jin, J., and Howells, R. D. (1995) Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. USA 92, 12436-12440.
100. 100. Watson, B., Meng, F., and Akil, H. (1996) A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands. Neurobiol. Dis. 3, 87-96.
101. 101. Watson, S. J., Akil, H., Ghazarossian, V. E., and Goldstein, A. (1981) Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies. Proc. Natl. Acad. Sci. USA 78, 1260-1263.
102. 102. Watson, S. J., Akil, H., Richard III, C. W., and Barchas, J. D. (1978) Evidence for two separate opiate peptide neuronal systems. Nature 275, 226-228.
103. 103. Willner, P., Ahlenius, S., Muscat, R., and Scheel-Kruger, J. (1991) The mesolimbic dopamine system. In The Mesolimbic Dopamine System: From Motivation to Action (P. Willner, and J. Scheel-Kruger, Eds.). Wiley, England.
104. 104. Wolozin, B. L., and Pasternak, G. W. (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA 78, 6181-6185.
105. 105. Xue, J. C., Chen, C., Zhu, J., Kunapuli, S. P., De Kiel, J. K., Yu, L., and Liu-Chen, L. Y. (1995) The third extracellular loop of the μ opioid receptor is important for agonist selectivity. J. Biol. Chem. 270, 12977-12979.
106. 106. Xue, J. C., Chen, C.-G., Zhu, J. M., Kunapuli, S., deRiel, J. K., Lei, Y, and Liu-Chen, L.-Y. (1994) Differential binding domains of peptide and non-peptide ligands in the cloned rat κ opioid receptor. J. Biol. Chem. 269, 30195-30199.
107. 107. Yasuda, K., Espinosa, R., III, Takeda, J., Le Beau, M. M., and Bell, G. I. (1994) Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. Genomics 19, 596-597.
108. 108. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., and Bell, G. I. (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90, 6736-6740.
109. 109. Zagon, I., Goodman, S., and McLaughlin, P. (1989) Characterization of zeta: A new opioid receptor involved in growth. Brain Res. 482, 297-305.
110. 110. Zahm, D. S., and Heimer, L. (1988) Ventral striatopallidal parts of the basal ganglia in the rat. I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J. Comp. Neurol. 272, 516-535.